Nobilis Therapeutics
PrivateLast Round
Grant
Sep 30, 2021
Total Funding Raised
$831,992
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nobilis Therapeutics operates in Healthcare & Life Sciences and is based in Portland, Oregon. Its latest recorded funding round was a Grant round in September 2021.
Nobilis Therapeutics is a biotechnology company that develops inhalation-based therapeutics using inert gas mixtures and portable delivery devices for the treatment of psychiatric and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nobilis Therapeutics Comparables
Compare Nobilis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rheos Medical Corp. | 79% | |
| GH Research | 77% | |
| Nexalis Therapeutics Limited | 77% |
For institutional investors. Book with your work email.
Nobilis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 30, 2021 | ||||
| Debt | Feb 15, 2018 | ||||
| Seed | Sep 7, 2016 |
For institutional investors. Book with your work email.
Nobilis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 425% MoM, from 274 to 1.4K.
- Feb 15, 2018
$500K debt round completed.
For institutional investors. Book with your work email.
Nobilis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nobilis Therapeutics's valuation, stock price, and market status.
Is Nobilis Therapeutics a public or private company?
Nobilis Therapeutics is a private company.
What is the current stock price of Nobilis Therapeutics?
Nobilis Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nobilis Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nobilis Therapeutics worth (valuation)?
Valuation information for Nobilis Therapeutics is not publicly available.
Can I buy Nobilis Therapeutics stock?
Nobilis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nobilis Therapeutics's last funding round?
Nobilis Therapeutics's most recent funding round was Grant on September 30, 2021.
Who are the main investors in Nobilis Therapeutics?
Key investors in Nobilis Therapeutics include National Institutes of Health (NIH).
Will Nobilis Therapeutics IPO soon?
No public IPO plans have been announced for Nobilis Therapeutics.
How can I track Nobilis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nobilis Therapeutics's shares on secondary markets.